OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis
Yigang Zhang, Yi Tan, Shuangchi Liu, et al.
Toxicology Mechanisms and Methods (2022) Vol. 33, Iss. 1, pp. 47-55
Open Access | Times Cited: 46
Yigang Zhang, Yi Tan, Shuangchi Liu, et al.
Toxicology Mechanisms and Methods (2022) Vol. 33, Iss. 1, pp. 47-55
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 165
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 165
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 153
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 153
The role of lipid metabolic reprogramming in tumor microenvironment
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 67
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 67
Natural products as chemo-radiation therapy sensitizers in cancers
Sabah Nisar, Tariq Masoodi, Kirti S. Prabhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113610-113610
Open Access | Times Cited: 51
Sabah Nisar, Tariq Masoodi, Kirti S. Prabhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113610-113610
Open Access | Times Cited: 51
Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal
Suneel Kumar, Stephen O. Mathew, Ravindra Prasad Aharwal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 160-160
Open Access | Times Cited: 33
Suneel Kumar, Stephen O. Mathew, Ravindra Prasad Aharwal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 160-160
Open Access | Times Cited: 33
Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy
Qiuhong Li, Kexin Chen, Tianyi Zhang, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175913-175913
Closed Access | Times Cited: 32
Qiuhong Li, Kexin Chen, Tianyi Zhang, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175913-175913
Closed Access | Times Cited: 32
Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer
Jaewang Lee, Jong‐Lyel Roh
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166788-166788
Closed Access | Times Cited: 28
Jaewang Lee, Jong‐Lyel Roh
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166788-166788
Closed Access | Times Cited: 28
Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
Xinyue Zhu, Xudong Sha, Yan Zang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3621-3637
Open Access | Times Cited: 11
Xinyue Zhu, Xudong Sha, Yan Zang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3621-3637
Open Access | Times Cited: 11
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
Ferroptosis: a potential therapeutic target for stroke
Chengli Liu, Guijun Wang, Wenrui Han, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 988-997
Open Access | Times Cited: 19
Chengli Liu, Guijun Wang, Wenrui Han, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 988-997
Open Access | Times Cited: 19
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 18
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 18
Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms
Zhichao Xing, Anping Su, Mi Li, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2909-2929
Open Access | Times Cited: 17
Zhichao Xing, Anping Su, Mi Li, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2909-2929
Open Access | Times Cited: 17
Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance
Jiawen Chen, Sibao Chen, Guoqing Chen
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 709-27
Open Access | Times Cited: 17
Jiawen Chen, Sibao Chen, Guoqing Chen
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 709-27
Open Access | Times Cited: 17
Withanolides: Promising candidates for cancer therapy
Qiang Zhang, Yongkang Yuan, Shijie Cao, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1104-1158
Closed Access | Times Cited: 7
Qiang Zhang, Yongkang Yuan, Shijie Cao, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1104-1158
Closed Access | Times Cited: 7
A guide to ferroptosis in cancer
Fatma Isil Yapici, Christina M. Bebber, Silvia von Karstedt
Molecular Oncology (2024) Vol. 18, Iss. 6, pp. 1378-1396
Open Access | Times Cited: 7
Fatma Isil Yapici, Christina M. Bebber, Silvia von Karstedt
Molecular Oncology (2024) Vol. 18, Iss. 6, pp. 1378-1396
Open Access | Times Cited: 7
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
Roberta Veglia Tranchese, Sabrina Battista, Laura Cerchia, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1443-1443
Open Access | Times Cited: 6
Roberta Veglia Tranchese, Sabrina Battista, Laura Cerchia, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1443-1443
Open Access | Times Cited: 6
Ferroptosis in Cancer Progression
Rongyu Zhang, Jinghong Chen, Saiyang Wang, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1820-1820
Open Access | Times Cited: 15
Rongyu Zhang, Jinghong Chen, Saiyang Wang, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1820-1820
Open Access | Times Cited: 15
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
Molecular mechanisms of Asparagus racemosus willd. and Withania somnifera (L.) Dunal as chemotherapeutic adjuvants for breast cancer treatment
Keshava Prasad, Akash Saggam, Kanive Parashiva Guruprasad, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118261-118261
Open Access | Times Cited: 4
Keshava Prasad, Akash Saggam, Kanive Parashiva Guruprasad, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118261-118261
Open Access | Times Cited: 4
Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells
Genshi Zhao, Yanying Liu, Xia Wei, et al.
Marine Drugs (2024) Vol. 22, Iss. 8, pp. 357-357
Open Access | Times Cited: 4
Genshi Zhao, Yanying Liu, Xia Wei, et al.
Marine Drugs (2024) Vol. 22, Iss. 8, pp. 357-357
Open Access | Times Cited: 4
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges
Lin Gan, Weimin Wang, Jinxiu Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Lin Gan, Weimin Wang, Jinxiu Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Natural compounds and programmed necrosis: pioneering a new frontier in cancer treatments
Md. Al Amin, Hasna Bouhenni, Mehrukh Zehravi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Md. Al Amin, Hasna Bouhenni, Mehrukh Zehravi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The Central Role of Ferroptosis-Induced Therapy Mediated by Tenacissoside H in Anaplastic Thyroid Cancer
W. He, Xiaotian Hu, Minghua Ge, et al.
Journal of Ethnopharmacology (2025), pp. 119908-119908
Closed Access
W. He, Xiaotian Hu, Minghua Ge, et al.
Journal of Ethnopharmacology (2025), pp. 119908-119908
Closed Access
Covalent binding of withanolides to cysteines of protein targets
Christian Bailly
Biochemical Pharmacology (2024) Vol. 226, pp. 116405-116405
Open Access | Times Cited: 3
Christian Bailly
Biochemical Pharmacology (2024) Vol. 226, pp. 116405-116405
Open Access | Times Cited: 3
Molecular targets and mechanisms of anti-cancer effects of withanolides
Zhiruo Zhang, Yueying Yang, Yang Xu, et al.
Chemico-Biological Interactions (2023) Vol. 384, pp. 110698-110698
Closed Access | Times Cited: 9
Zhiruo Zhang, Yueying Yang, Yang Xu, et al.
Chemico-Biological Interactions (2023) Vol. 384, pp. 110698-110698
Closed Access | Times Cited: 9
